Case Report - Archives of Medical Case Reports (2022) Volume 4, Issue 1
Imatinib, Tyrosine kinase inhibitor (TKI), Hypopigmentation, Hyperpigmentation, CML, GIST, Rash, Cutaneous adverse effect, Neutropenia